CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2023; 13(01): 028-031
DOI: 10.1055/s-0042-1744358
Original Article

Glycemic Status and Maternal Outcome among Women with Gestational Diabetes Mellitus

Reena Wilma Frank
1   Department of OBG Nursing, Yenepoya Deemed to be University, Mangaluru, Karnataka, India.
Devina E. Rodrigues
2   Department of Community Health Nursing, Father Muller College of Nursing, Mangaluru, Karnataka, India
Rajagopal Kaipangala
3   Department of Obstetrics and Gynaecology, Srinivas Institute of Medical Science and Research Center, Mangaluru, Karnataka, India
4   Yenepoya College of Nursing, Yenepoya Deemed to be University, Deralakatte, Mangaluru, Karnataka, India
Prema D. Cunha
3   Department of Obstetrics and Gynaecology, Srinivas Institute of Medical Science and Research Center, Mangaluru, Karnataka, India
› Author Affiliations


Introduction Maternal gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. GDM can adversely affect the short- and long-term health of mothers and their newborns.

Aim This study aims to determine the association between maternal glycemic parameters with adverse maternal outcomes and baseline characteristics among women with GDM.

Settings and Design Observational, prospective study.

Materials and Methods Sixty-six pregnant women visiting outpatient department of a parent hospital who were diagnosed with GDM by an obstetrician were included in the study. Glycemic parameters were documented at the time of diagnosis (at 24 weeks of pregnancy). The maternal outcomes were studied after 24 hours of delivery.

Results The mean age of the women was 29.05 ± 3.98 years and 36.4% of the women were primipara. Among 66 women, 47% had a family history of diabetes mellitus, and that 48.28% of them belonged to first-degree relatives. Body mass index indicated in prepregnancy status 39.4% of them were overweight. In glycemic parameters, 63.6 and 93.9% of the women had increased fasting blood sugar and postprandial blood sugar values, respectively. Hemoglobin A1c (HbA1c) was elevated in 45.5% of the women. The maternal outcome showed that 30.30% of the women underwent cesarean section, 18.18% had preeclampsia, and 15.16% of them had increased weight gain (>11kg). There was a significant association between HbA1c and preeclampsia, p = 0.044.

Conclusions The study reiterates that GDM has a poor maternal outcome, the mother is at risk to develop preeclampsia, increased maternal weight gain, and interference of cesarean section is more.

Clinical Significance During the antenatal period among GDM mothers' glycemic control is very essential. Any variation in the glycemic parameters of the mother will lead to poor maternal outcomes.

Source(s) of Support


Publication History

Article published online:
18 April 2022

© 2022. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 (Suppl. 01) S62-S67 PubMed/NCBI View Article: Google Scholar.
  • 2 International Diabetes Federation. IDF Diabetes Atlas. 9th edition.. Brussels, Belgium: International Diabetes Federation; 2019
  • 3 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486 PubMed/NCBI View Article: Google Scholar
  • 4 Zhuang W, Lv J, Liang Q, Chen W, Zhang S, Sun X. Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures. Exp Ther Med 2020; 20 (04) 3361-3367
  • 5 Farrar D, Simmonds M, Bryant M. et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 2016; 354: i4694 DOI: 10.1136/bmj.i4694.
  • 6 Wei Y, Xu Q, Yang H. et al. Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: a population-based cohort study in China. PLoS Med 2019; 16 (10) e1002926
  • 7 Unnikrishnan B, Singh A, Rathi P, Bhat SK, Ravishankar N, Nayak PH, Praveen O. Risk factors of gestational diabetes mellitus: a hospital-based pair-matched case-control study in coastal South India. South Afr J Obstet Gynaecol 2020; 26 (01) 13-17
  • 8 Ma X, Zhang T. The effect of blood glucose control on pregnancy outcomes in pregnant women with gestational diabetes mellitus. Int J Clin Exp Med 2017; 10: 15510-5
  • 9 Muche AA, Olayemi OO, Gete YK. Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia. BMC Pregnancy Childbirth 2020; 20 (01) 73
  • 10 Bhat M, Ramesha KN, Sarma SP, Menon S, Ganesh Kumar S. Outcome of gestational diabetes mellitus from a tertiary referral center in South India: a case-control study. J Obstet Gynaecol India 2012; 62 (06) 644-649
  • 11 Sathiamma PK, Karunakaran L. A prospective study on maternal and perinatal outcome of gestational diabetes mellitus. Int J Reprod Contracept Obstet Gynecol 2017; 6 (07) 2933-39
  • 12 Zheng Y, Shen Y, Jiang S. et al. Maternal glycemic parameters and adverse pregnancy outcomes among high-risk pregnant women. BMJ Open Diabetes Res Care 2019; 7 (01) e000774
  • 13 Buhary BM, Almohareb O, Aljohani N. et al. Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: a retrospective study. Indian J Endocrinol Metab 2016; 20 (04) 481-490
  • 14 Nicolosi BF, Vernini JM, Costa RA. et al. Maternal factors associated with hyperglycemia in pregnancy and perinatal outcomes: a Brazilian reference center cohort study. Diabetol Metab Syndr 2020; 12: 49 DOI: 10.1186/s13098-020-00556.